Caritas Neuro Solutions has struck the partnership deal with Mumbai-based Innvocept Solutions as part of its strategy to become a world leader in mental health and neurology research.
I am delighted that we have managed to make this partnership work...we’ll be able to make a much more significant impact and really change lives...Leigh Fell, Chief Executive, Caritas Neuro Solutions
The capital firm is now able to run full-service pharmaceutical and biotechnology clinical trials across the globe with staff based throughout India, Malaysia, Sri Lanka and Singapore in addition to existing capabilities across Europe.
Caritas, which launched in April 2017, is one of the world’s first commercial clinical research organisations to specialise solely in neurological diseases and also a first in running the company in a social enterprise-style business model.
The company’s profits are re-invested into running academic trials in mental health and mindset studies on behalf of charities and public sector organisations...